Fullerton, CA7 Active Studies

Ankylosing Spondylitis Clinical Trials in Fullerton, CA

Find 7 actively recruiting ankylosing spondylitis clinical trials in Fullerton, CA. Connect with local research sites and explore new treatment options.

7
Active Trials
6
Sponsors
5,907
Enrolling

Recruiting Ankylosing Spondylitis Studies in Fullerton

About Ankylosing Spondylitis Clinical Trials in Fullerton

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 7 ankylosing spondylitis clinical trials recruiting participants in Fullerton, CA. These studies are seeking a combined 5,907 participants. Research is being sponsored by Merck Sharp & Dohme LLC, AstraZeneca, Bristol-Myers Squibb and 3 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in Fullerton — FAQ

Are there ankylosing spondylitis clinical trials in Fullerton?

Yes, there are 7 ankylosing spondylitis clinical trials currently recruiting in Fullerton, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Fullerton?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Fullerton research site will contact you about next steps.

Are clinical trials in Fullerton free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Fullerton studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 7 active trials in Fullerton are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated July 18, 2026 from ClinicalTrials.gov